12 Jun 2015

TruScreen reports smaller loss than last year

2:48 pm on 12 June 2015

Cervical cancer screening company, TruScreen, has reported a smaller annual loss than last year, as it invests to meet demand from new markets.

The firm reported a loss of $692,000 in the 12 months to March, compared to a loss of $1.58 million the previous period.

Revenue was ahead of forecast at $2.2 million.

Its chief executive, Martin Dillon, said China, which represented about two thirds of global sales, was a focus.

He said getting regulatory approval in some markets had taken longer than expected.

But Mr Dillon said the firm was confident of better results in the current year.